Topics

Biogen gains rights to 2 eye drugs by Samsung Bioepis in $100M deal

04:44 EST 7 Nov 2019 | SmartBrief

Biogen has partnered with Samsung Bioepis, a joint venture with South Korea's Samsung BioLogics, to strengthen its presence i -More

Original Article: Biogen gains rights to 2 eye drugs by Samsung Bioepis in $100M deal

NEXT ARTICLE

More From BioPortfolio on "Biogen gains rights to 2 eye drugs by Samsung Bioepis in $100M deal"

Quick Search

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...